Inspiring Stories of Real People Who Turned Pain into Purpose
Los Angeles, CA, April 26, 2021 — In the aftermath of hardship or trauma, it’s perfectly natural to enter what Dr. Randall Bell terms the “Dive Stage.” After all, the rug has just been pulled out from under you. But with the right strategies, it’s possible to not only get back up and find your footing, but to also use the experience to grow in entirely new directions.
“How do you take that energy from the trauma and tap into it to do something really remarkable that you wouldn’t have done otherwise?” asks Dr. Bell.
Stories of real people (many of them familiar) who have done exactly that unfold in his latest book, Post-Traumatic Thriving: The Art, Science, & Stories of Resilience.
Among the inspirational journeys Dr. Bell shares are:
• A deaf man with a glass eye invented the electric guitar and became a household name, remarkably wealthy and most importantly, happy.
• A convicted murderer took responsibility for the damage he caused, graduated with honors from college, became a minister and turned around the hearts of the most hardened criminals.
• A girl born with cerebral palsy landed the world’s first starring role on national television and spoke at the White House three times.
• A woman hid in a basement for years and lost her entire family in the Holocaust. She eventually found true love and paints stunning artwork.
• The sister of a murder victim helped millions of women in toxic domestic relationships.
• A woman’s car crash resulted in an addiction to prescription drugs, a divorce, a loss of her children and a cot in a homeless shelter. She has rebuilt it all back and more.
• A man set to go to the Olympics had his hopes dashed by Jimmy Carter and went on to build a worldwide business empire.
Dr. Bell juxtaposes outcomes of scientific studies with these stories to reveal common denominators among “thrivers.” He divides his insights into three sections: The Dive Stage, The Survive Stage and The Thrive Stage, and outlines a step-by-step process toward authentic healing.
Post-Traumatic Thriving documents the science of happiness, as well as the individual styles and common thread that all post-traumatic thrivers have to emerge with a fulfilling life. When trauma hits, your most significant decision will be to dive, survive or thrive. If you choose to thrive, this book is for you.
As a socio-economist, Dr. Randall Bell has consulted on more disasters on earth than anyone in history and is widely considered the world’s top authority in the field of post-traumatic thriving. His clients include the Federal Government, State Governments, International Tribunals, major corporations and homeowners. Dr. Bell believes that “the problem is not the problem — the problem is how we react to the problem.”
Often called the “Master of Disaster,” Dr. Bell is squarely focused on authentic recovery and resilience. His research has been profiled on major television shows and featured in numerous magazines and the international media. More information can be found at www.posttraumaticthriving.com.
Post-Traumatic Thriving: The Art, Science, & Stories of Resilience
RYAH GROUP INC. (FORMERLY, PRIME BLOCKCHAIN INC.) ANNOUNCES CLOSING OF REVERSE TAKEOVER TRANSACTION
Verdun, Quebec , April 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – RYAH Group Inc. (formerly, Prime Blockchain Inc.) (the “Company”) is pleased to announce the closing of its previously announced reverse takeover transaction (the “Transaction”) with Potbotics Inc. (“Potbotics”). The Transaction was effected by way of a triangular merger between the Company, Potbotics, and a wholly-owned, Florida subsidiary of the Company (“AcquisitionCo”) pursuant to the laws of the State of Florida. The combined public company resulting from the Transaction (the “Resulting Issuer”) will carry on the business of Potbotics.
About Potbotics Inc.
Potbotics is a company operating out of New York, which, directly and through its wholly-owned subsidiary RYAH Medtech Inc., is engaged in the development and commercialization of various innovative technology solutions (both software and hardware) for the plant-based medical industry. Since its formation, Potbotics has been focused on leveraging its know-how in predictive analytics to pioneer products to be used within its suite of vertically-integrated technologies, to provide users with added control over their health and wellness. As an emerging company, Potbotics is striving to establish itself as a leader in delivering innovative, user-friendly IoT devices in the plant-based medical industry. By utilizing its know-how in fields such as artificial intelligence and predictive analytics, Potbotics is moving towards building a portfolio of vertically-integrated products that facilitate harmonized data collection throughout the complete medical plant lifecycle, from seed to consumption.
Proposed Listing of the Company
The Company is a reporting issuer in the Provinces of British Columbia, Quebec, and Alberta. On April 1, 2021, the Company received the conditional approval of the Canadian Securities Exchange (the “CSE”) to list the subordinate voting shares in the capital of the Company (the “Subordinate Voting Shares”) on the CSE. As of the date of this press release, the Company is working towards meeting the listing requirements of the CSE, and subject to the final approval of the CSE, the Subordinate Voting Shares are expected to commence trading on the CSE under the ticker symbol “RYAH”. The Company intends to announce the exact date of the commencement of trading in due course by way of a further press release.
New Board and Management
As part of the Transaction, the management and board of directors of the Company was reconstituted to consist of the following individuals: Gregory Wagner (Chief Executive Officer and Director), Jeannine Kingsley (Chief Financial Officer), Irina Migalina (Director), George Anastassov (Director), and Binyomin Posen (Director). Additional information regarding the business of the Company and the biographical details of management and the board of directors of the Company may be found in the Company’s CSE Form 2A - Listing Statement (the “Listing Statement”), which is expected to be filed on SEDAR under the Company’s profile prior to the commencement of trading of the Subordinate Voting Shares on the CSE.
The Transaction
The Transaction was effected by way of a triangular merger between the Company, Potbotics, and AcquisitionCo pursuant to the laws of the State of Florida. As a result of the Transaction (i) each shareholder of Potbotics received 0.035 super voting share in the capital of the Company (each whole share, a “Super Voting Share”) for each share of common stock, no par value, of Potbotics (“Potbotics Share”) held, and (ii) all unexercised options of Potbotics adjusted automatically such that, upon exercise, such options entitle the holders thereof to acquire Super Voting Shares at the same ratio and with a corresponding adjustment to the exercise price.
Except as otherwise prescribed by the Canada Business Corporations Act, at a meeting of shareholders of the Company, each Super Voting Share entitles the holder thereof to one hundred (100) votes in respect of each Super Voting Share held at such meetings, and subject to certain limitations, each Super Voting Share is convertible into one hundred (100) Subordinate Voting Shares. Additional information regarding the Super Voting Shares may be found in the Listing Statement, which is expected to be filed on SEDAR under the Company’s profile prior to the commencement of trading of the Subordinate Voting Shares on the CSE.
Following completion of the Transaction, including the conversion of an aggregate of 229,859 Super Voting Shares held by Canadian securityholders into approximately 22,985,900 Subordinate Voting Shares, there are expected to be an aggregate of 201,576,818 Subordinate Voting Shares and approximately 2,920,019 Super Voting Shares (which may be converted in accordance with their terms into approximately 292,001,900 Subordinate Voting Shares) issued and outstanding. Of these issued and outstanding Resulting Issuer Shares, (i) former shareholders of Potbotics hold (A) 2,920,019 Super Voting Shares, representing 100% of the Super Voting Shares issued and outstanding, and (B) 22,985,877 Subordinate Voting Shares, representing 11.40% of the Subordinate Voting Shares issued and outstanding, (ii) the original shareholders of the Company hold 34,789,098 Subordinate Voting Shares, representing approximately 17.26% of the issued and outstanding Subordinate Voting Shares, (iii) subscribers in certain financings completed by the Company prior to the completion of the Transaction hold 127,226,843 Subordinate Voting Shares, representing approximately 63.11% of the issued and outstanding Subordinate Voting Shares, and (iv) a certain third party finder holds 15,000,000 Subordinate Voting Shares, representing approximately 7.44% of the issued and outstanding Subordinate Voting Shares, in each of the foregoing cases on a non-diluted basis.
As part of the Transaction, approximately CND$2.4 million, representing the proceeds of certain financings completed by the Company prior to the completion of the Transaction have been deposited into escrow with a third-party escrow agent, to be released upon receipt of the final approval of the CSE to list the Subordinate Voting Shares on the CSE.
Additional Information
The Super Voting Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold absent registration or an applicable exemption from the registration requirement. The Subordinate Voting Shares have not been and will not be registered under the Securities Act and may not be offered or sold in the United States or to a U.S. Person (as defined in in Rule 902(k) of Regulation S under the Securities Act) absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
For additional information on the Company:
Mr. Gregory Wagner C.E.O. and Director Telephone: 1-917-210-0543 Email: gwagner@ryah.com
Cautionary Statements
This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and includes, but is not limited to, statements about (i) the listing of the Subordinate Voting Shares on the CSE and the timing thereof, (ii) the business plans and expectations of the Company, the issuance of and timing associated with issuing a further comprehensive press release or press releases, and expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Resulting Issuer. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: (i) changes in general economic, business and political conditions, including changes in the financial markets, changes in applicable laws and regulations both locally and in foreign jurisdictions, (ii) compliance with extensive government regulation and the costs associated with compliance, (iii) the risks and uncertainties associated with foreign markets, and (iv) risks associated with the COVID-19 pandemic. This forward-looking information may be affected by risks and uncertainties in the business of the Resulting Issuer and market conditions. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. The Company does not intend, nor assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Author Featured in Netflix series Surviving Death Shares Story of Hope and Evidence of Afterlife
New York, NY, April 26, 2021 — Imagine being a bartender at a busy Broadway show when just before intermission, you get the call – your too young dad has suddenly died. As your family’s screams of despair pierce your ear and instantly shatter your world, hundreds of patrons abuzz with energy from the comedic first act descend on you. They hastily begin ordering drinks, and somehow a shell that looks like you makes them, while your inside crumbles away. How do we move forward when such a devastating loss befalls us?
Love, Dad intimately shares one family’s darkest hours and their road to healing, a road that has been long ignored or scoffed at by the scientific community. Mike Anthony, a healthy skeptic, goes to great lengths to uncover the paradigm-shifting research into the nature of consciousness that exists, and shows us why it must be put back in the forefront with no shame attached.
Love, Dad details Anthony’s true story as he pulls himself out of despair, and alongside his family, finds true connection and communication with his dad once again. Given the transformative nature of the experience, he couldn’t help but share what happened, hoping to bring others the peace he’d discovered. So compelling is his story that Netflix chose to feature it in three episodes of their series Surviving Death.
This eye-opening book pushes the boundaries of what we think we know, unlocking the door to new and exhilarating possibilities. What might it be like to know that death is truly not the end? In Love, Dad we get one family’s answer.
When a stranger’s unpredictable phone call delivers a message that Anthony’s dad had contacted her from “the other side,” it kicks off a chain of events that would entirely change his family’s perspective on life, death and the transcendent nature of love. Join him on his remarkable quest, as his skeptical mindset gets challenged and eventually overruled through an extraordinary journey, leading to an event that would forever change his understanding of reality.
“Though I’ve always wondered, since I was a child,” Anthony remarks, “about what we are and how and why we’re here, and what happens to us when we die, I did not imagine I’d ever have such direct evidence to suggest that something, something ‘other worldly’ does, indeed, happen to us.”
Everyone needs this book. Our largest looming fear is death, and our greatest pain is the grief we feel when someone we love dies. But what if we knew that death is just a doorway, and loss is really just an alteration of relationship? Could we all live with a greater sense of peace if we knew our “lost” loved ones are actually very close by, and our own “passing” is simply that — a passage through? Anthony now knows the answer and you can, too!
Most importantly, Love, Dad gives us the hope that is so desperately needed during these times and does so with honesty, grace and evidence.
“The Netflix series Surviving Death, in which a part of my story is told, explores evidence that impacts every human being on the planet. Evidence of things that science says are impossible. And yet, they happen. I know they do. Because I have seen them. In Love, Dad: How My Father Died ...Then Told Me He Didn’t, I tell the story of how I came to know, without doubt, that our science has much yet to uncover.”
About Mike Anthony Mike Anthony has been a professional actor and (not-professional) bartender since he graduated from Wayne State University with a Master of Arts degree in Theater. His first book, Life At Hamilton, chronicles the extraordinary time he spent as a theater bartender with an up-close perspective of Hamilton: An American Musical as it rocketed into Broadway history.
Beyond his life in theater, Anthony’s journey took an unexpected turn when his dad passed, leading him down a remarkable path of discovery. He now spends a good portion of his time exploring evidence suggestive of the survival of consciousness beyond the demise of the physical body.
He uses his acting abilities, often during the Christmas season, at the Theatre at Monmouth in Maine. He is still the bar manager at Hamilton, though on hiatus due to Covid. He currently lives in Milford, CT.
Love, Dad: How My Father Died... Then Told Me He Didn't Publisher: Waterside Productions ISBN-10: 1951805666 ISBN-13: 978-1951805661 Available from Amazon.com
###
16 People, Impacted by Depression, Contribute Their Unforgettable Journeys to Encourage Dialogue
Bayview, Idaho, April 26, 2021 — The voice on the other end of the phone was familiar but shaky. It was Sarah’s friend Carolyn, and she was grappling with suicidal ideation.
“Something had her in its grip and would not let go,” Sarah Zabel explains. “I kept wondering, what’s doing this? How does a normal, happy person come to feel life is so bad that she must kill herself?”
Sarah shares Carolyn’s unforgettable story, along with the emotional journeys of 15 others, in Fighting Chance: How Unexpected Observations and Unintended Outcomes Shape the Science and Treatment of Depression.Included are interviews with more than 20 experts in the fields of neuroscience and psychiatry, plus current research, to give readers a 360-degree look inside the world of mental illness.
Described by Sarah as a “science book for non-scientists,” Fighting Chancetackles key questions that have guided scientific research for decades and delves into the discoveries that have formed the medical world’s understanding of the disorder. Peppered throughout are more than 20 illustrations that help explain the science involved — making it widely accessible.
Sarah adeptly explores topics ranging from the neurobiology of depression to antidepressant medications; stress and inflammation; genetics; suicide; traditional and alternative therapies and treatments; and even gives a nod to Big Data’s efforts to clarify depression’s causes and cures.
Ultimately, Fighting Chance is a tale of human endeavor and ingenuity, of downright weird experiments and serendipitous discoveries, and of people who valiantly battle for answers for themselves and for people they will never know.
Author Sarah Zabel graduated from the U.S. Air Force Academy with a degree in computer science in 1987 and was commissioned a second lieutenant. She retired from the Air Force in 2018 as a major general and decided to turn her focus to her life-long love of learning and become a science writer. She set herself the task of first coming to understand, and then to explain for other lay-persons, the science behind some of life’s most complex but important human experiences. Inspired, intrigued and frustrated by an enduring friend’s battle with depression, she set that topic as her first task. Sarah does occasional consulting and other activities associated with her time as one of the military’s leaders in cyberspace operations and security, in the provision of communications and other services to a community, and leadership of a diverse workforce.
Healthcare Excellence Canada supports essential care partners to safely re-enter health and care settings during COVID-19
New program and resources for healthcare organizations and caregivers
OTTAWA, ON, April 26, 2021 /CNW/ - Healthcare Excellence Canada has launched a program to support the safe presence of essential care partners in hospitals, long-term care homes and other health and care settings during COVID-19, including during lockdowns.
The pandemic led to blanket visitor restrictions that prohibited essential care partners from being with loved ones in health and care settings. Although the restrictive policies were put in place with the best intentions, they have contributed to other risks and unintended harm to patients and families, as well as moral distress to staff.
To help healthcare organizations safely re-integrate, welcome and engage essential care partners as part of their care teams during COVID-19 and beyond, Healthcare Excellence Canada has launched Essential Together. This program is based on co-created policy guidance that can be applied to all health and care settings in Canada, regardless of their pandemic status.
To specifically support essential care partners with loved ones in long-term care, Healthcare Excellence Canada has also published a new resource - Safely Re-entering Long-Term Care Homes During COVID-19: A Resource for Essential Care Partners. Created by essential care partners for essential care partners, it includes detail about what to expect while entering a home and being part of the care team during the pandemic.
"Essential care partners are different from general visitors. An essential care partner is a person who provides physical, psychological and emotional support, as deemed important by a patient, resident, or client," says Lisa Poole, who was one of the caregiver advisors who contributed to creating the resource and is advising the ongoing design of the Essential Together program.
"This can include support in decision-making, care coordination and continuity of care, including things like assistance with meals, recreation and hygiene," Poole adds.
"Evidence suggests that with proper support and education, family and essential care partners can safely participate in care during the pandemic, contributing to better care, well-being, and experiences," says Jennifer Zelmer, President and CEO of Healthcare Excellence Canada.
"Leading organizations have worked with their communities over the last year on creative ways to re-integrate essential care partners, practices that are evolving as vaccines roll out," says Zelmer.
"Programs like Essential Together offer ways to share this knowledge so more people can benefit."
About Essential Together
Essential Together is working with organizations to adapt co-created policy guidance to identify and prepare essential care partners and then support them as they enter healthcare settings, during the pandemic and beyond. There are learning bundles available with resources curated from across the country and huddles that create peer-to-peer exchanges. Organizations that formerly register for the program can receive dedicated coaching and other support.
Healthcare Excellence Canada is an organization with a relentless focus on improving healthcare, with – and for – everyone in Canada. Launched in March 2021 from the amalgamation of the Canadian Patient Safety Institute and the Canadian Foundation for Healthcare Improvement, Healthcare Excellence Canada has greater capacity to support partners to turn proven innovations into widespread and lasting improvement in patient safety and all the dimensions of healthcare excellence. We believe in the power of people and evidence and know that by connecting them, we can achieve the best healthcare in the world. HEC is an independent, not-for-profit charity funded primarily by Health Canada. www.healthcareexcellence.ca
The views expressed herein do not necessarily represent the views of Health Canada.
SOURCE Healthcare Excellence Canada
In the Shadow of Lies, Bi-racial Woman Struggles to Find Love, Family and Faith
Dallas, TX, April 23, 2021 — Natalia Foster pretends it doesn’t matter that she’s never known her biological father and that she’s never had a real father-daughter bond. She pretends it doesn’t affect her relationships with men, and that she doesn’t despise him for what he did. But she does.
Natalia’s biological father, Joe, was a handsome man of Italian descent when he met her beautiful mother, who’s Black. Although he was married with three children when they met, it hadn’t stopped them from conceiving Natalia. Twenty-eight years later, Joe’s wife and family still know nothing of Natalia’s existence. But when word spreads that Joe has a terminal illness, Natalia feels compelled to meet him and salvage what little time with him she has left. But at what cost to Joe’s devoted wife, Rosa, and their grown children?
The Wool Over Their Eyes, from Dione Martin, is an authentic, heartfelt story about complex family dynamics and the emotions that must be unpacked when long-buried secrets push their way to the surface.
In the midst of Natalia’s family drama and pain is also a love story. Natalia must choose between two loves — a long-lost one and a new one. Her ex-boyfriend, Tyler Davis, who captured her heart and connected with her soul, resurfaces. But she meets a handsome doctor, David Duplessis, who’d cared for her father. Just as the relationship begins to blossom, David commits an act that severs her trust and sends her spiraling further into her dark abyss.
The Wool Over Their Eyes is loosely based on Martin’s personal experiences. She drew upon her own memories and insights of growing up without her biological father and being betrayed in her own marriage to inform her narrative and give her characters depth and authenticity.
“I wrote The Wool Over Their Eyes for fatherless girls, for women who have been betrayed, for those who have been rejected because of their race (or otherness) and for families that have been torn apart by secrets, lies and deception,” Martin reflects. “Healing is possible – through change, through empathy, through faith and through forgiveness.”
Author Dione Martin was born and raised in New Orleans, where she spent much of her childhood and teen years reading. She earned her Bachelor’s in English from the University of Minnesota-Morris and her Master’s in Journalism from the University of Texas at Austin. She is currently a senior communications director at Brinker International. She lives in Dallas with her two daughters and enjoys running, cooking, performing arts and attempting DIY projects. The Wool Over Their Eyes is her debut novel, and she is working on her next one.
“About Natalie is groundbreaking. It doesn’t preach or pretend to offer a panacea. Instead, it offers a refreshing, authentic look at one family’s struggle with addiction, easily the most powerful book published on the subject in the 21st century.”— Dr. Maryel McKinley PhD, Addictions Expert, Former Co-Host, “All Talk Recovery Radio,” Los Angeles, Arbitron rated No. 1 in Southern California
Pittsburgh, PA, April 23, 2021 — Like the band that played on as the Titanic sank, Christine Naman unpacked the groceries and made a meatloaf — the simple act of normalcy distracting her from an unthinkable reality: addiction was pulling her daughter under.
“Even with the picture of the situation coming more clearly into focus, I clung to denial like a kayaker who has been thrown from his boat would cling to a branch lying across the water,” Christine says. “It is amazing how deep into denial a person can go and how strongly they can hang onto it before reality smacks them around enough so that they let go.”
Christinetraces her daughter's years-long battle with addiction in About Natalie, a gripping, cautionary tale of how, in spite of a loving family and a comfortable life, a child can end up on the wrong path, meet the wrong people and get lost in the unthinkable.
About Natalie takes readers deep inside Christine’s emotional and mental turmoil as she grows into her new, unfortunate role as the parent of an addict. She steps on syringes left on the floor and wrestles one from the family dog’s mouth. She lives the nightmare of finding an unresponsive child on the floor and uses Narcan to revive her. She chases away a drug dealer and stays up all night waiting for her missing child to come home. She rejoices during periods of recovery and hope and is devastated during relapses. When her daughter suffers, Christine suffers right along with her.
Interwoven with Christine’s reflections are Natalie’s compelling poems that share her personal pain and the unvarnished truth of her struggle.
At its core, About Natalie is a story of fighting for — and right alongside — the ones we love, no matter how difficult the circumstances. It is a story of keeping the faith, battling hard and never giving up.
Bestselling author Christine Pisera Naman is a wife to a beautiful man named Peter and a mother to three fantastic kids named Jason, Natalie and Trevor. In her free time, she enjoys crocheting, which she does poorly; painting, again poorly; and volunteering at her local hospital, which she hopes she does well. She is the author of the Faces of Hope series of books that are now housed in the 9/11 Memorial Museum in New York City. Her other works include Caterpillar Kisses, Christmas Lights, The Novena and The Believers.About Natalie is her heart poured onto paper.
She hopes that by sharing her family’s difficult story she can bring understanding and knowledge to those who do not know the problem firsthand as well as provide comfort to those who know the nightmare of addiction all too well.
Harness the Power of Your Emotions to Reach Your Full Potential
"Feeling Forwards helps you find the power within to overcome unbelievable challenges and take a quantum leap forwards." — TONY ROBBINS
New York, NY, April 23, 2021 — To create meaningful changes in yourself or to achieve something you’ve never done before takes more than deep thought and new habits. Emotion is the secret sauce that can move you from just thinking about the life you want to actually living the life you want.
In Feeling Forwards: How to Become the Person Who Has the Life You Want, author and coach Elizabeth Gould shares techniques and strategies that are accessible and actionable to anyone wanting to realize big dreams or simply transform themselves in everyday situations.
“Feeling Forwards is a process that myself and many other successful people have used to harness the power of emotions to behave as though they already are the people they wish to be,” Elizabeth says. “Whether you want to grow and succeed far beyond your current circumstances, find your soulmate, improve your finances … whatever you’re aiming for, it all starts with harnessing the power of your emotions.”
What exactly is “feeling forwards”? In a nutshell, it’s adopting the behaviors now that suit the lifestyle you want to enjoy in the future.
The first half of Feeling Forwards is a fascinating deep-dive into the science proving the true power of our emotions, enabling them to travel forward and backward in time, influence pre-programmed computer outcomes, reverse aging, impact crime rates, fast-track personal reinvention and much more. After understanding the effects that our emotions can truly have on our lives, Elizabeth offers practical applications of the strategies in Feeling Forwardsusing real-life examples of those who’ve successfully integrated the principles into their lives.
Woven throughout are Elizabeth’s candid, personal stories of embracing these principles to thrive through several life-threatening events and dramatic personal upheavals.
The result is a refreshingly relatable, actionable guide to help you create the life you genuinely want to live. Feeling Forwards teaches you how to become the person who has the life you want … today. As Elizabeth reveals, “Today is the past of your future.”
About the Author
A bestselling author and founding member of Randi Zuckerberg’s global leadership school at the Zuckerberg Institute, Elizabeth Gould experiences the joy of working with people around the world to unlock their potential. She has spent decades interviewing thousands of successful professionals to understand how they behave to achieve what they want. Her work is endorsed by world-renowned life and business strategist, Tony Robbins. Feeling Forwards is her third book.
Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- This World Meningitis Day (April 24th), Meningitis Foundation Canada (MFC) is raising awareness of this ‘indiscriminate killer disease’ and calling on all Canadian provincial and territorial policymakers to act to #DefeatMeningitis by 2030.
“This call aligns with the newly ratified ‘Global Roadmap to Defeat Meningitis by 2030’,” said MFC spokesperson, Michael Redfearn. The newly ratified ‘Global Roadmap to Defeat Meningitis’ is led by a WHO-multi-organization partnership.
Understandably, countries worldwide are focused on COVID-19. Tragically, the pandemic also threatens to bring back diseases that we can largely prevent, like meningitis. The pandemic has caused disruptions in immunization services and once many people are vaccinated and able to gather again, the number of cases of infectious diseases like meningitis are expected to rise.
Dr. Joanne Langley, infectious disease physician and MFC senior medical advisor, says, “The pandemic has helped the world realize the life-saving potential of vaccines. While we focus on providing access to COVID-19 vaccines, it is important to remember to keep up to date on all immunizations so that we are protected against meningitis, blood infections, pneumonia and many other serious illnesses.”
In honor of World Meningitis Day, the CN Tower will display the green, blue, and teal colours of the MFC logo, to draw attention to a deadly though vaccine preventable disease. As it does most evenings, beginning at sunset, a standard light show from the CN Tower will run for 8 minutes at the top of every hour, followed by another light show on the half hour. The night lighting will be visible by webcam on the CN Tower website.
Meningitis is a potentially deadly inflammation of the brain and spinal cord, which result from infection by bacteria, viruses, and fungi. Bacterial meningitis is the most severe type and is a medical emergency. It can strike quickly, be difficult to diagnose, and can lead to death in a matter of hours. Even with prompt diagnosis and treatment, approximately 10% of patients die and up to 20% or more sustain permanent damage and disability such as loss of limbs, deafness, and cognitive impairment. There are effective vaccines now available to protect against many of the bacteria that cause meningitis and septicemia.
Health Canada initiates the review of the rolling submission for the first Canadian-based COVID-19 vaccine candidate
QUEBEC CITY, April 23, 2021 /CNW Telbec/ - Medicago, a biopharmaceutical company headquartered in Quebec City is pleased to announce that Health Canada received for review the first portion of Medicago's plant-derived COVID-19 vaccine candidate rolling submission on April 19, 2021.
The Interim Order (IO) rolling submission allows Medicago to submit nonclinical sections, quality and clinical safety, and efficacy information as they become available for Health Canada's immediate review to accelerate the overall review process. Health Canada will not decide on whether to authorize any vaccine being considered under the IO rolling review until it has received the complete evidence to support the risk/benefit decision based on safety, efficacy and quality of the COVID-19 vaccine candidate.
"Health Canada's decision to accept for review the IO rolling submission for Medicago's vaccine, the first Canadian-based COVID-19 vaccine submission, meets an important milestone.," said Carolyn Finkle, Chief Operating Officer of Medicago. "We are grateful to Health Canada and look forward to continuing to work with them as they move forward with review of our COVID-19 vaccine IO rolling submission."
In parallel with the review of the rolling submission, Medicago is conducting the Phase 3 trial. The last portion of the IO rolling submission will be filed after the COVID-19 vaccine efficacy and safety endpoint of the Phase 3 trial is reached.
"We are pleased with the interactions with the Canadian regulatory authority, and we appreciate their guidance and confidence in Medicago to pursue the IO rolling submission in Canada for our COVID-19 vaccine candidate" said Judith Atkins, Vice-President Regulatory Affairs at Medicago.
Medicago has received regulatory approval to launch the Phase 3 portion of its Phase 2/3 clinical development in Canada, USA, UK and Brazil.
Medicago's plant-derived vaccine candidate against COVID-19 uses Coronavirus-Like-Particle (CoVLP) technology with the vaccine composed of recombinant spike (S) glycoprotein expressed as virus-like-particles (VLPs) co-administered with GSK's pandemic adjuvant. Two doses of 3.75 micrograms of CoVLP are administered 21 days apart.
The Phase 3 portion of the study is an event-driven, randomized, observer-blinded, placebo-controlled, two-way cross-over design that will evaluate the efficacy and safety of the adjuvanted CoVLP formulation, compared to placebo. The study will enroll up to 30,000 subjects initially composed of healthy adults (18y to 65y), followed by elderly adults (65y+) and adults with comorbidities. The trial will take place in 10 countries pending regulatory approvals, starting with Canada, the USA, the UK, and Brazil enrolling males and females from ethnically and racially diverse populations.
Medicago is on a mission to improve global public health using the power of plants. Founded in 1999 with the belief that innovative approaches and rigorous research would bring new solutions in healthcare, Medicago is a pioneer in plant-derived therapeutics. We are proudly rooted in Quebec, with manufacturing capacity in both Canada and the US. Our passionate and curious team of over 500 scientific experts and employees are dedicated to using our technology to provide rapid responses to emerging global health challenges, and to advancing therapeutics against life-threatening diseases worldwide.
SOURCE Medicago
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
